AMT-151 in Patients With Selected Advanced Solid Tumours
NCT 05498597 Brief Summary This first-in-human study will evaluate the Maximum Tolerated…
Read more arrow_forwardNCT 05498597 Brief Summary This first-in-human study will evaluate the Maximum Tolerated…
Read more arrow_forwardNCT 05906862 Brief Summary This first-in-human study will evaluate the Maximum Tolerated…
Read more arrow_forwardACTRN 12620000583943 Brief Summary The purpose of this study is to examine…
Read more arrow_forwardNCT 03175224 Brief Summary To assess: efficacy of APL-101 as monotherapy for…
Read more arrow_forwardNCT 05807035 Brief Summary Phase 1 trial to evaluate the feasibility of…
Read more arrow_forwardNCT 06219941 Brief Summary The purpose of this study is to assess…
Read more arrow_forwardACTRN 12619001308189 Brief Summary This study aims to find out how well…
Read more arrow_forwardNCT 06756932 Brief Summary The purpose of this study is to assess…
Read more arrow_forwardNCT 06120283 Brief Summary This is a dose escalation and dose expansion…
Read more arrow_forwardNCT 04862663 Brief Summary A Phase Ib/III Open-label, Randomised Study of Capivasertib…
Read more arrow_forward